Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: Fitzhughlaw who wrote (43265)	6/14/2017 11:15:00 AM
From: samcat500	Respond to of 63276

I surprised you didn't call 'Ace' a Joker : )

To: Fitzhughlaw who wrote (43265)	6/14/2017 12:51:32 PM
From: CelebrityEquity	Read Replies (1) \| Respond to of 63276

I'm not sure if this is ON TOPIC or OFF TOPIC or if it violates the Terms of Service (I view it more as a Term of Endearment) by commenting on a post and a poster but...I gotta say it: Mr. Fitzhugh...YOU. ARE. THE. MAN. If I'm going to get hauled (and mauled) into court by the SI - IMMU Police... I request Michael Fitzhugh be my legal representative. Thank you.

To: Fitzhughlaw who wrote (43265)	6/14/2017 5:15:28 PM
From: GCowan	Read Replies (2) \| Respond to of 63276

Hallo - you seem like an angry little man, but seem to be knowledgeable of the company. I found this abstract from ASCO abstracts.asco.org It essentially implies that they have made significant progress in categorizing TNBC into subsegments. This is of great important to what my colleagues and I consider to be relevant in the field, and furthermore has excellent implications for IMMU-132 P3 trials, as they will be able to tailor their treatment to a more specific patient which should yield wonder for the ORR. There was a write up on this in a cancer journal which coincided with an uptick in the stock in the earlier. I think that this is being underappreciated by the market. What are your thoughts? You appear to be a lawyer but are you capable of understanding the science? Very looking forward to hearing your opinion. -GC